1986
DOI: 10.1203/00006450-198601000-00018
|View full text |Cite
|
Sign up to set email alerts
|

Medium- and Long-Chain Dicarboxylic Aciduria in Patients with Zellweger Syndrome and Neonatal Adrenoleukodystrophy

Abstract: ABSTRACT. This study reports that patients with neonatal adrenoleukodystrophy andIn rat liver, 6-oxidation of both VLCFA (1-3) and DA (4) occurs mostly in peroxisomes, only a minor fraction of these substrates being oxidized in mitochondria (3, 4).The accumulation of VLCFA in brain, adrenal glands, fibroblasts, and plasma of patients with ZS and NALD (5-8) have been attributed to a blockade of the peroxisomal oxidation of these fatty acids (3). We report here that odd-and even-numbered DA are excreted in exces… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
26
0

Year Published

1986
1986
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(28 citation statements)
references
References 14 publications
2
26
0
Order By: Relevance
“…Consistent with a previous report on the increased excretion of long-chain dicarboxylic acids, including C16, in patients with Zellweger syndrome and neonatal adrenoleukodystrophy (10), the mechanism behind the accumulation of dicarboxylic acylcarnitines is probably related to the microsomal generation of dicarboxylic acids. Under all conditions, there is some -oxidation of long-chain fatty acids, including C16:0 and C18:0, that produces the corresponding dicarboxylic acids, followed by activation by a microsomal dicarboxylyl-CoA synthetase (11).…”
Section: Discussionsupporting
confidence: 77%
“…Consistent with a previous report on the increased excretion of long-chain dicarboxylic acids, including C16, in patients with Zellweger syndrome and neonatal adrenoleukodystrophy (10), the mechanism behind the accumulation of dicarboxylic acylcarnitines is probably related to the microsomal generation of dicarboxylic acids. Under all conditions, there is some -oxidation of long-chain fatty acids, including C16:0 and C18:0, that produces the corresponding dicarboxylic acids, followed by activation by a microsomal dicarboxylyl-CoA synthetase (11).…”
Section: Discussionsupporting
confidence: 77%
“…In contrast, plasma levels of docosanoic acid (C22:0) are decreased in these patients (18). An excess of long-chain hydroxylated fatty acids and dicarboxylic acids was found in urine of patients with peroxisomal biogenesis disorders (19). Based on these data, we postulate that -oxidation of (very) long-chain fatty acids may provide an alternative route for fatty acid metabolism.…”
mentioning
confidence: 63%
“…decanedioyl-and octadecanedioyl-carnitine in plasma of PBD patients by tandem mass spectrometry (11) and the excretion of C16DCA in urine of PBD patients (9). The small residual activity found could be either mitochondrial or result from peroxisomal enzymes mislocalized in the cytosol.…”
Section: Downloaded Frommentioning
confidence: 99%